Eudaimonia Asset Management »

Nektar Therapeutics shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $549k 13k 42.28
2025-09-30 $4.4M 78k 56.26
2025-06-30 $624k 24k 25.84

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Advanced Energy Industries Common Stock (AEIS)
nLight Common Stock (LASR)
Fabrinet Common Stock (FN)
TTM Technologies Common Stock (TTMI)
Madrigal Pharmaceuticals Common Stock (MDGL)
Bridgebio Pharma Common Stock (BBIO)
Guardant Health Common Stock (GH)
Dycom Industries Common Stock (DY)
Sanmina Corp Common Stock (SANM)
Zurn Elkay Water Solutions Corp Common Stock (ZWS)
Hecla Mining Common Stock (HL)
Turning Point Brands Common Stock (TPB)
Blackrock Funds - Equities ETF (SMIN)
Protagonist Therapeutics Common Stock (PTGX)

View all positions for Eudaimonia Asset Management

Top funds holding Nektar Therapeutics

BVF
Susquehanna International
Vanguard Group
Citadel Advisors
Two Seas Capital
BlackRock
Millennium Management
Prosight Management
Invesco
Point72 Asset Management
Sofinnova Ventures
Two Sigma Investments
Emerald Advisers
22NW
Qube Research & Technologies

View all funds holding Nektar Therapeutics